loader

nasdaq:ctmx

LATEST ARTICLES

CytomX Therapeutics Announces Business Update and Company Milestones for 2026

CytomX Therapeutics to Present at Upcoming December Investor Conferences

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer Annual Meeting

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer

CytomX Therapeutics to Present at Upcoming September Investor Conferences

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES